Paul Sevelda Selected Research

Paul Sevelda Research Topics

Disease

14	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2003
6	Neoplasms (Cancer) 06/2012 - 04/2002
3	Neoplasm Metastasis (Metastasis) 12/2022 - 05/2009
2	Osteoporosis 01/2019 - 08/2015
2	Colorectal Neoplasms (Colorectal Cancer) 03/2012 - 04/2008
1	Residual Neoplasm 01/2021
1	Disease Progression 01/2021
1	Pathologic Complete Response 01/2021
1	Bone Fractures (Bone Fracture) 01/2021
1	Unilateral Breast Neoplasms 05/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Adenocarcinoma 01/2019
1	Osteoarthritis 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Cataract (Cataracts) 01/2019
1	Metabolic Bone Diseases (Osteopenia) 08/2015
1	Arthralgia (Joint Pain) 08/2015
1	Febrile Neutropenia 06/2012
1	Infections 06/2012
1	Neutropenia 06/2012
1	Liver Failure 06/2012
1	Ovarian Epithelial Carcinoma 11/2010
1	Alopecia (Baldness) 11/2010
1	Hypersensitivity (Allergy) 11/2010
1	Nausea 11/2010
1	Ovarian Neoplasms (Ovarian Cancer) 11/2010
1	Thrombocytopenia (Thrombopenia) 11/2010
1	Vomiting 11/2010
1	Hand-Foot Syndrome 11/2010
1	Sepsis (Septicemia) 10/2010
1	Anemia 04/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2006
1	Type I Syndactyly 01/2005

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 12/2022 - 04/2002
4	Aromatase InhibitorsIBA 12/2022 - 08/2015
3	Denosumab FDA Link 12/2022 - 08/2015
2	L-BLP25IBA 01/2021 - 01/2020
2	Anastrozole (Arimidex)FDA LinkGeneric 01/2021 - 03/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2012 - 04/2008
2	Estrogen ReceptorsIBA 03/2012 - 09/2011
2	PlatinumIBA 11/2010 - 06/2003
1	AnthracyclinesIBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	Cancer VaccinesIBA 01/2020
1	RANK LigandIBA 08/2015
1	Docetaxel (Taxotere)FDA Link 06/2012
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2012
1	antineoplaston A10 (A 10)IBA 06/2012
1	Tamoxifen FDA LinkGeneric 03/2012
1	ParaffinIBA 09/2011
1	Formaldehyde (Formol)FDA Link 09/2011
1	RNA (Ribonucleic Acid)IBA 09/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2011
1	AntiemeticsIBA 11/2010
1	1-dodecylpyridoxal (PLD)IBA 11/2010
1	taxaneIBA 11/2010
1	thiaclopridIBA 11/2010
1	liposomal doxorubicin (Doxil)FDA Link 11/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Carboplatin (JM8)FDA LinkGeneric 11/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2010
1	AntigensIBA 10/2010
1	Fulvestrant (Faslodex)FDA Link 05/2009
1	thiamine triphosphorate (TTP)IBA 05/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2009
1	Methotrexate (Mexate)FDA LinkGeneric 04/2008
1	Hemoglobins (Hemoglobin)IBA 04/2008
1	Fluorouracil (Carac)FDA LinkGeneric 04/2008
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2006

Therapy/Procedure

7	Therapeutics 12/2022 - 05/2009
6	Drug Therapy (Chemotherapy) 01/2021 - 06/2003
3	Adjuvant Chemotherapy 03/2012 - 06/2003
2	Radiotherapy 01/2019 - 06/2012
1	Prophylactic Mastectomy 05/2019
1	Lymph Node Excision (Lymph Node Dissection) 06/2011
1	Premedication 11/2010
1	CMF regimen 04/2008
1	Combination Drug Therapy (Combination Chemotherapy) 04/2008
1	Mastectomy (Mammectomy) 04/2008
1	Segmental Mastectomy (Lumpectomy) 04/2008